Kenneth Frazier
Kenneth Frazier | |
|---|---|
| Born | Kenneth Carleton Frazier December 17, 1954 Philadelphia, Pennsylvania, U.S. |
| Education | Pennsylvania State University, University Park (BA) Harvard University (JD) |
| Occupation(s) | Executive chairman, Merck & Co. |
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies). He was elected to the American Philosophical Society in 2018.
Frazier was included in Time's list of the most influential people in the world in 2018 and 2021.